Key result
Single-lead AI-ECG indicating LVEF ≤ 40% predicts ~93% higher two-year major cardiovascular events risk.
Why the study?
It was unknown whether AI applied to a single-lead ECG can predict the two-year risk of MACE and all-cause mortality independent of LVSD.
Does an AI-ECG algorithm predicting LVEF ≤ 40% predict MACE and all-cause mortality in patients undergoing routine echocardiography?
Observational (n=1,007)
Yes
Does an AI-ECG algorithm predicting LVEF ≤ 40% predict MACE and all-cause mortality in patients undergoing routine echocardiography?
Answers are grounded in this paper and cite their sources.
An AI-ECG algorithm applied to a single-lead ECG can predict long-term MACE and mortality independently of actual echocardiographic LVEF, suggesting utility as a point-of-care risk stratification tool.
Aims Artificial intelligence (AI) applied to a single-lead electrocardiogram (AI-ECG) can detect impaired left ventricular systolic dysfunction [LVSD: left ventricular ejection fraction (LVEF) ≤ 40%]. This study aimed to determine if AI-ECG can also predict the two-year risk of major adverse cardiovascular events (MACE) and all-cause mortality independent of LVSD. Methods and results Clinical outcomes after two-year follow-up were collected on patients who attended for routine echocardiography and received simultaneous single-lead-ECG recording for AI-ECG analysis. MACE and all-cause mortality were compared by Cox regression, measured against the classification of LVEF > or ≤40%. A subgroup analysis was performed on patients with echocardiographic LVEF ≥ 50%. With previously established thresholds, ‘positive’ AI-ECG was defined as an LVEF-predicted ≤40%, and negative AI-ECG signified an LVEF-predicted >40%; 1007 patients were included for analysis (mean age, 62.3 years; 52.4% male). 339 (33.7%) had an AI-ECG-predicted LVEF ≤ 40% and had a higher MACE rate (LVEF ≤ 40% vs. >40%: 34.2% vs.11.9%; adjusted hazard ratio (aHR) 1.93; 95% CI, 1.39–2.69; P < 0.001), primarily driven by increased mortality (23% vs. 9.6%; P < 0.001; aHR 1.56; 95% CI, 1.06–2.29; P = 0.0239). In patients with echocardiographic LVEF ≥ 50%, there was a higher incidence of MACE in those with an AI-ECG ‘false positive’ prediction of LVEF ≤ 40% (27.2% vs.11.9%; P < 0.001; aHR 1.71 and 95% CI, 1.11–2.47) and all-cause mortality (20.4% vs. 9.6%; P < 0.001; aHR 1.59, 95% CI, 1.09–2.42). Conclusion An AI-ECG algorithm designed to detect LVEF ≤ 40% can also identify patients at risk of MACE and all-cause mortality from single-lead ECG recording—independent of actual LVEF on echo. This requires further evaluation as a point-of-care risk stratification tool.
No takes yet. Share an insight, caveat, or question.
Alrumayh et al. (2025) conducted an observational in Patients attending routine transthoracic echocardiogram (n=1,007). AI-ECG predicting LVEF ≤ 40% vs. AI-ECG predicting LVEF > 40% was evaluated on Major adverse cardiovascular events (MACE) (aHR 1.93, 95% CI 1.39-2.69, p=<0.001). An AI-ECG algorithm predicting LVEF ≤ 40% from a single-lead ECG independently predicted a higher two-year risk of major cardiovascular events compared to a negative prediction.
Synapse has enriched 10 related papers. Consider them for comparative context: